Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 27;22(4):507.
doi: 10.3390/molecules22040507.

New Benzimidazole-1,2,4-Triazole Hybrid Compounds: Synthesis, Anticandidal Activity and Cytotoxicity Evaluation

Affiliations

New Benzimidazole-1,2,4-Triazole Hybrid Compounds: Synthesis, Anticandidal Activity and Cytotoxicity Evaluation

Hülya Karaca Gençer et al. Molecules. .

Abstract

Owing to the growing need for antifungal agents, we synthesized a new series 2-((5-(4-(5-substituted-1H-benzimidazol-2-yl)phenyl)-4-substituted-4H-1,2,4-triazol-3-yl)thio)-1-(substitutedphenyl)ethan-1-one derivatives, which were tested against Candida species. The synthesized compounds were characterized and elucidated by FT-IR, ¹H-NMR, 13C-NMR and HR-MS spectroscopies. The synthesized compounds were screened in vitro anticandidal activity against Candida species by broth microdiluation methods. In vitro cytotoxic effects of the final compounds were determined by MTT assay. Microbiological studies revealed that compounds 5m, 5o, 5r, 5t, 5y, 5ab, and 5ad possess a good antifungal profile. Compounds 5w was the most active derivative and showed comparable antifungal activity to those of reference drugs ketoconazole and fluconazole. Cytotoxicity evaluation of compounds 5m, 5o, 5r, 5w, 5y, 5ab and 5ad showed that compounds 5w and 5ad were the least cytotoxic agents. Effects of these two compounds against ergosterol biosynthesis were observed by LC-MS-MS method, which is based on quantification of ergosterol level in C. albicans. Compounds 5w and 5d inhibited ergosterol biosynthesis concentration dependently. A fluorescence microscopy study was performed to visualize effect of compound 5w against C. albicans at cellular level. It was determined that compound 5w has a membrane damaging effect, which may be related with inhibition of biosynthesis of ergosterol.

Keywords: 1,2,4-triazole; NIH/3T3; antifungal activity; cytotoxicity; ergosterol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Synthesis route to target compounds 5a5ad.
Figure 1
Figure 1
SARs outline of the compounds (5a5ad).
Figure 2
Figure 2
Relative Ergosterol Level (REL) of C. albicans (ATCC 24433) after treatment with compounds 5w and 5ad fluconazole and ketoconazole.
Figure 3
Figure 3
Visualization of C. albicans culture under fluorescence microscope: (A) C. albicans, incubated without compound; and (B) C. albicans, incubated with compound 5w.

Similar articles

Cited by

References

    1. Whibley N., Gaffen S.L. Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species. Cytokine. 2015;76:42–52. doi: 10.1016/j.cyto.2015.07.025. - DOI - PMC - PubMed
    1. Sparber F., LeibundGut-Landmann S. Interleukin 17-mediated host defense against Candida albicans. Pathogens. 2015;4:606–619. doi: 10.3390/pathogens4030606. - DOI - PMC - PubMed
    1. Jiang Y., Cao Y., Zhang J., Zou Y., Chai X., Hu H., Zhao Q., Wu Q., Zhang D., Jiang Y., et al. Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one. Eur. J. Med. Chem. 2011;46:3135–3141. doi: 10.1016/j.ejmech.2011.02.001. - DOI - PubMed
    1. Altıntop M.D., Kaplancıklı Z.A., Turan-Zitouni G., Özdemir A., İşcan G., Akalın G., Yıldırım Ş. Synthesis and anticandidal activity of new triazolothiadiazine derivatives. Eur. J. Med. Chem. 2011;46:5562–5566. - PubMed
    1. Georgopapadakou N.H., Walsh T.J. Human mycoses: Drugs and targets for emerging pathogens. Science. 1994;264:371–373. doi: 10.1126/science.8153622. - DOI - PubMed

LinkOut - more resources